在结核病药物发现的脚手架跳跃:原则,应用和案例研究
Ondrej Kovar1,2, Martin Kufa1,2, Vladimir Finger1,2
1Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic.
Journal of medicinal chemistry
|October 7, 2025
概括
脚手架跳跃是一种药物化学策略,它修改药物结构以对抗耐药结核病 (TB). 这种方法加快了发现新的结核病治疗方法,提高了疗效和安全性.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 结核病治疗药物 结核病治疗药物
背景情况:
- 结核病 (TB) 仍然是一个重大的全球健康威胁,由耐药性Mycobacterium tuberculosis (Mtb) 菌株加剧.
- 现有的抗结核药物面临局限性,包括毒性和耐药性的出现.
研究的目的:
- 探索架跳跃在开发新型抗结核病疗法中的应用.
- 突出脚手架跳跃在克服当前结核病药物的局限性方面的作用.
主要方法:
- 对应于Mycobacterium结核病 (Mtb) 药物发现的架子跳跃策略的审查.
- 分析涉及针对关键Mtb途径的结构修改的案例研究.
- 考虑传统和in silico方法对脚手架跳跃.
主要成果:
- 脚手架跳跃成功地发现了针对重要的mtb途径的新型化合物,如能量代谢和细胞壁合成.
- 这种方法导致了具有增强的药理动力学特性,有效性和降低毒性的化合物.
- 脚手架跳跃有助于规避现有的耐药性机制.
结论:
- 脚手架跳跃是一种多功能和创新的药物化学策略,用于加速结核病药物发现.
- 它为开发下一代抗结核病药物提供了一个有希望的途径,能够解决耐药性并改善治疗结果.
相关概念视频
Pulmonary Tuberculosis V
516
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Pulmonary Tuberculosis I
800
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
800
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis IV
461
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
461
Pulmonary Tuberculosis III
879
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
879
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K


